INOZYME PHARMA, INC. Accrued Professional Fees, Current
INOZYME PHARMA, INC. had Accrued Professional Fees, Current of $1.70 million as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedProfessionalFeesCurrent · last filed 2025-03-10
- 2024-12-31: Accrued Professional Fees, Current $1.70M.
- 2023-12-31: Accrued Professional Fees, Current $1.38M.
- 2023-06-30: Accrued Professional Fees, Current $1.46M.
- 2023-03-31: Accrued Professional Fees, Current $1.76M.
| Period end | Accrued Professional Fees, Current | Accrued Professional Fees, Current as first filed |
|---|---|---|
| 2024-12-31 | $1.70M 10-K · filed 2025-03-10 | |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-10 | |
| 2023-06-30 | $1.46M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.76M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.31M 10-K · filed 2024-03-12 | $746.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $524.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $469.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $590.00K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $727.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $641.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $545.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $418.00K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $454.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $480.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.11M 10-Q · filed 2020-09-03 | |
| 2019-12-31 | $268.00K 10-K · filed 2021-03-25 |